Katarina Vučićević

19PUBLICATIONS
29CO-AUTHORS
AutoimmunityRheumatology and arthritisCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 28, 2026
Unlocking the Potential of Population Pharmacokinetic Models of Adalimumab in Patients with Crohn's Disease.

|Jul 24, 2026
Pharmacokinetic model selection for infliximab based on inflammatory bowel disease phenotype and severity: Toward model-informed precision dosing.

|Jul 01, 2026
Rethinking Anti-CD20 Therapies: From Fixed to Precision Dosing.

|Jun 26, 2026
Prioritizing Antidiabetic Drugs for Inflammatory Bowel Disease Through Inverse Signal Detection: A FAERS Pharmacovigilance Study.

|May 27, 2026
Population Pharmacokinetic Models at the Forefront of Precision Dosing.

|Mar 28, 2026
Identification of Drug Repurposing Opportunities of Immunomodulatory Drugs for Inflammatory Bowel Disease Through Inverse Pharmacovigilance Signal Detection in the FAERS Database.

Katarina Đogatović, Katarina Vučićević, Milena Kovačević

Pageof 4

Frequent Collaborators

6 joint publications

Branislava Miljković

4 joint publications

Đorđe Kralj

4 joint publications

Petar Svorcan

4 joint publications

Marija Jovanović